NCT07072377

Brief Summary

Brief Summary The goal of this clinical trial is to evaluate the acceptability and adherence of low- and high-intensity remote nutritional interventions for cancer patients in rural and urban areas, specifically focusing on those with invasive cancer who are about to start treatment. The main question\[s\] it aims to answer are: Can low- and high-intensity remote nutritional interventions improve adherence to cancer treatment and quality of life? What is the impact of nutritional support on treatment delays, unplanned healthcare utilization, and dietary modifications? Researchers will compare the low-intensity arm (initial nutritional consultation plus written materials) to the high-intensity arm (1-hour consultation, monthly follow-ups, and written materials) to see if higher intensity interventions lead to better outcomes in terms of adherence, quality of life, and healthcare utilization. Participants will: Receive either a low- or high-intensity nutritional consultation. Complete surveys assessing quality of life, dietary habits, treatment delays, and unplanned healthcare use. Be asked to participate in monthly follow-up consultations (for the high-intensity group) to track progress and provide additional support.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Sep 2025Sep 2028

First Submitted

Initial submission to the registry

May 22, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

September 10, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

2.6 years

First QC Date

May 22, 2025

Last Update Submit

February 2, 2026

Conditions

Keywords

Cancer Nutrition InterventionMalnutrition in Cancer PatientsNutritional Support for CancerPrehabilitation Program for CancerRural Cancer NutritionQuality of Life and Cancer NutritionRemote Nutritional ConsultationsCancer Treatment Outcomes and Nutrition

Outcome Measures

Primary Outcomes (2)

  • Adherence to Assigned Nutritional Intervention (Low- vs. High-Intensity)

    Adherence will be assessed over the 6-week intervention period using two metrics: 1. Proportion of scheduled dietary counseling contacts completed (≥70% completion threshold), and 2. Participant self-report of meeting ≥70% of individualized nutrition goals, recorded weekly. Adherence will be summarized as the percentage of participants in each arm who meet both criteria. Unit of Measure: Percentage of participants meeting adherence threshold (%)

    6 months

  • Acceptability of Nutritional Intervention Based on Participant Survey

    Acceptability will be measured at the end of the 6-week intervention using a structured participant survey developed for the study. This survey includes Likert-scale questions (e.g., ease of use, satisfaction, perceived helpfulness) and open-ended feedback. Responses will be analyzed to compare acceptability between low- and high-intensity intervention arms. Unit of Measure: Mean score on acceptability survey

    6 months

Secondary Outcomes (4)

  • Change in Quality of Life Measured by the PROMIS Global Health Scale

    6 months

  • Patient-Reported Dietary Behavior Change

    Unit of Measure: Proportion of participants reporting positive dietary change (%)

  • Frequency of Treatment Delays or Modifications During Chemoradiation

    6 months

  • Unplanned Healthcare Utilization (ER Visits and Unplanned Hospitalizations)

    6 months

Study Arms (6)

Rural, Remote, Low-Intensity

EXPERIMENTAL

Rural, Remote, Low-Intensity

Behavioral: Intensity of Nutritional Intervention

Rural, Remote, High-Intensity

EXPERIMENTAL

Rural, Remote, High-Intensity

Behavioral: Intensity of Nutritional Intervention

Urban, Remote, Low-Intensity

EXPERIMENTAL

Urban, Remote, Low-Intensity

Behavioral: Intensity of Nutritional InterventionBehavioral: Remote or In-Person

Urban, Remote, High-Intensity

EXPERIMENTAL

Urban, Remote, High-Intensity

Behavioral: Intensity of Nutritional InterventionBehavioral: Remote or In-Person

Urban, In-Person, Low-Intensity

EXPERIMENTAL

Urban, In-Person, Low-Intensity

Behavioral: Intensity of Nutritional InterventionBehavioral: Remote or In-Person

Urban, In-Person, High-Intensity

EXPERIMENTAL

Urban, In-Person, High-Intensity

Behavioral: Intensity of Nutritional InterventionBehavioral: Remote or In-Person

Interventions

Participants will either receive High or Low intensity nutritional support.

Rural, Remote, High-IntensityRural, Remote, Low-IntensityUrban, In-Person, High-IntensityUrban, In-Person, Low-IntensityUrban, Remote, High-IntensityUrban, Remote, Low-Intensity

Patients will either receive their support in-person or remotely.

Urban, In-Person, High-IntensityUrban, In-Person, Low-IntensityUrban, Remote, High-IntensityUrban, Remote, Low-Intensity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of invasive cancer with plans to initiate chemo-, immune-, targeted-, or hormonal therapy for treatment of their malignancy, or within one month of starting treatment.
  • Age ≥ 18 years of age.
  • Patients must be able to read, write, and speak English as study material and virtual nutrition consultation calls are only available in English.
  • Patients receiving treatment at a participating ambulatory medical oncology site.
  • Willingness to have a remote nutritional consultation and complete questionnaires/surveys.
  • Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.

You may not qualify if:

  • Diagnosis of acute leukemia (these patients generally receive predominantly inpatient care).
  • Diagnosis of head \& neck cancer, esophageal cancer, gastric cancer, patients presenting with recognized cachexia or severe malnutrition, or patients with PEG tubes for enteral feeding.
  • Rationale: These patients would normally be referred for dietary consultation and may need ongoing clinical intervention from an on-site dietitian beyond the period of the proposed study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vermont Medical Center

Burlington, Vermont, 05401, United States

RECRUITING

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director-Faculty

Study Record Dates

First Submitted

May 22, 2025

First Posted

July 18, 2025

Study Start

September 10, 2025

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Anonymized patient related data will be incorporated into publications and will be made available to other investigators at reasonable request.

Locations